Rebiotix has raised $8.5 million in a $10 million offering, according to a regulatory document that the company filed yesterday with the SEC.
The offering, which consists of debt and convertible promissory notes, has garnered participation from 29 investors thus far, the company reported. Rebiotix said it is accepting minimum investments of $25,000 and that it doesn’t expect the offering to extend beyond a year.
Get the full story at our sister site, Drug Delivery Business News.
The post Rebiotix raises $8.5m for microbiome therapy appeared first on MassDevice.